1.1 This guide covers the evaluation of chitosan salts suitable for use in biomedical or pharmaceutical applications, or both, including, but not limited to, tissue-engineered medical products (TEMPS). 1.2 This guide addresses key parameters relevant for the functionality, characterization, and purity of chitosan salts. 1.3 As with any material, some characteristics of chitosan may be altered by processing techniques (such as molding, extrusion, machining, assembly, sterilization, and so forth) required for the production of a specific part or device. Therefore, properties of fabricated forms of this polymer should be evaluated using test methods that are appropriate to ensure safety and efficacy. This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use. |
ISO 13408-1: 1998: | Aseptic Processing of Health Care Products--Part 1: General Requirements |
Ph. Eur. | Monograph Chitosan Chloride, Nov. 2000 Available from EDQM, Publications and Services European Pharmacopoeia, BP 907 226, avenue de Colmar, F-67029 Strasbourg Cedex 1, France. |
F1906-98 | Standard Practice for Evaluation of Immune Responses In Biocompatibility Testing Using ELISA Tests, Lymphocyte, Proliferation, and Cell Migration |
F895-11(2016) | Standard Test Method for Agar Diffusion Cell Culture Screening for Cytotoxicity |
F813-20 | Standard Practice for Direct Contact Cell Culture Evaluation of Materials for Medical Devices |
F763-22 | Standard Practice for Short-Term Intramuscular Screening of Implantable Medical Device Materials |
F756-17 | Standard Practice for Assessment of Hemolytic Properties of Materials |
F749-20 | Standard Practice for Evaluating Material Extracts by Intracutaneous Injection in the Rabbit |
F748-16 | Standard Practice for Selecting Generic Biological Test Methods for Materials and Devices |
F619-20 | Standard Practice for Extraction of Materials Used in Medical Devices |
D2196-20 | Standard Test Methods for Rheological Properties of Non-Newtonian Materials by Rotational Viscometer |
F1905-98 | Standard Practice for Selecting Tests for Determining the Propensity of Materials to Cause Immunotoxicity |
F1251-89(1995) | Standard Terminology Relating to Polymeric Biomaterials in Medical and Surgical Devices |
F981-23 | Standard Practice for Assessment of Muscle and Bone Tissue Responses to Long-Term Implantable Materials Used in Medical Devices |
F1904-23 | Standard Guide for Testing the Biological Responses to Medical Device Particulate Debris and Degradation Products in vivo |
F1903-18 | Standard Practice for Testing for Cellular Responses to Particles in vitro |
F1439-03(2018) | Standard Guide for Performance of Lifetime Bioassay for the Tumorigenic Potential of Implant Materials |
|